WHO ICTRP trial

probiotics in chronic pancreatitis: influence on quality of life, digestion and…

DRKS00029257 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00029257
Public title probiotics in chronic pancreatitis: influence on quality of life, digestion and the gut microbiome
Scientific title probiotics in chronic pancreatitis: influence on quality of life, digestion and the gut microbiome
Primary sponsor Johannes Wesling Klinikum Minden
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type interventional
Countries Germany
Conditions K86.0 K86.1 K86.8;Alcohol-induced chronic pancreatitis;Other chronic pancreatitis;Other specified diseases of pancreas;K86.0;K86.1;K86.8
Interventions Group 1: SF-36 questionaire, lab work (Haemoglobin, Ferritin, HbA1c), weight/hight/BMI, Stool samples, supplementation of the study Probiotics (Verum) for 12 weeks. Verum (OMNi BiOTiC® HETOX) contains: • Lactobacillus acidophilus W37 •…
Registration date Aug 5, 2023
Target size 100
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations